Growth Rate of Corpus Callosum in Very Premature Infants

References

1. ↵
   Juul S. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischaemic brain damage. Acta Paediatr Suppl 2002;91:36–42

   CrossRefPubMed
2. ↵
   Crowther CA, Hiller JE, Doyle LW, Haslam RR. Australasian Collaborative Trial of Magnesium Sulphate (ACTOMgSO4) Collaborative Group: effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003;290:2669–2676

   CrossRefPubMedWeb of Science
3. Volpe JJ. Cerebral white matter injury of the premature infant—more common than you think. Pediatrics 2003;112:176–180

   FREE Full Text
4. ↵
   Shankaran S, Laptook A. Challenge of conducting trials of neuroprotection in the asphyxiated term infant. Semin Perinatol 2003;27:320–332

   CrossRefPubMedWeb of Science
5. ↵
   Peterson BS, Anderson AW, Ehrenkranz R, et al. Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics 2003;111:939–948

   Abstract/FREE Full Text
6. Pinto-Martin JA, Whitaker AH, Feldman JF, et al. Relation of cranial ultrasound abnormalities in low-birthweight infants to motor or cognitive performance at ages 2, 6, and 9 years. Dev Med Child Neurol 1999;41:826–833

   CrossRefPubMedWeb of Science
7. ↵
   Stewart AL, Rifkin L, Amess PN, et al. Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm. Lancet 1999;353:1653–1657

   CrossRefPubMedWeb of Science
8. ↵
   Miller SP, Scozzio, Goldstein RB, et al. Comparing the diagnosis of white matter injury in premature newborns with serial MR imaging and transfontanel ultrasonography findings. AJNR Am J Neuroradiol 2003;24:1661–1669

   Abstract/FREE Full Text
9. ↵
   Malinger G, Zakut H. The corpus callosum: normal fetal development as shown by transvaginal sonography. AJR Am J Roentgenol 1993;161:1041–1043

   PubMedWeb of Science
10. ↵
    Achiron R, Achiron A. Development of the human fetal corpus callosum: a high-resolution, cross-sectional sonographic study. Ultrasound Obstet Gynecol 2001;18:343–347

    CrossRefPubMedWeb of Science
11. ↵
    Cooke RW, Abernathy LJ. Cranial magnetic resonance imaging and school performance in very low birth weight infants in adolescence. Arch Dis Child Fetal Neonatal Ed 1999;81:F116–F121

    Abstract/FREE Full Text
12. ↵
    Santhouse AM, Ffytche DH, Howard RJ, et al. The functional significance of perinatal corpus callosum damage: an fMRI study in young adults. Brain 2002;125:1782–1792

    Abstract/FREE Full Text
13. ↵
    Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001;50:553–562

    CrossRefPubMedWeb of Science
14. ↵
    Johnston MV, Trescher WH, Ishidia Nakajima W. Neurobiology of hypoxic–ischemic injury in the developing brain. Pediatr Res 2001;49:735–741

    CrossRefPubMedWeb of Science
15. ↵
    Bayley N. Bayley scales of infant development. 2nd ed. San Antonio, TX: Psychological Corporation;1993
16. ↵
    Anderson NG, Warfield SK, Wells S, et al. A limited range of measures of 2-D ultrasound correlate with 3-D MRI cerebral volumes in the premature infant at term. Ultrasound Med Biol 2004;30:11–18

    CrossRefPubMedWeb of Science
17. ↵
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–310

    CrossRefPubMedWeb of Science
18. ↵
    Nosarti C, Rushe TM, Woodruff PW, et al. Corpus callosum size and very preterm birth: relationship to neuropsychological outcome. Brain 2004;127:2080–2089

    Abstract/FREE Full Text
19. ↵
    Dobbing J. The later development of the brain and its vulnerability. In: Davis JA, Dobbing J, eds. Scientific foundations of paediatrics. 2nd ed. London: Heinemann Medical;1981;744–759
20. ↵
    Pham D, Xu C, Prince J. Current methods in medical imaging segmentation. Annu Rev Biomed Eng 2000;2:315–337

    CrossRefPubMedWeb of Science
21. ↵
    Leviton A, Dammann O, Allred EN, et al. Antenatal corticosteroids and cranial ultrasonographic abnormalities. Am J Obstet Gynecol 1999;181:1007–1017

    CrossRefPubMedWeb of Science
22. ↵
    Agarwal R, Chiswick ML, Rimmer S, et al. Antenatal steroids are associated with a reduction in the incidence of cerebral white matter lesions in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2002;86:F96–F101

    Abstract/FREE Full Text
23. ↵
    Mercuri E, Jongmans M, Henderson S, et al. Evaluation of the corpus callosum in clumsy children born prematurely: a functional and morphological study. Neuropediatrics 1996;27:317–322

    PubMedWeb of Science
24. ↵
    Davatzikos C, Barzi A, Lawrie J, et al. Correlation of corpus callosum morphometry with cognitive and motor function in periventricular leukomalacia. Neuropediatrics 2003;34:247–252

    CrossRefPubMedWeb of Science
25. ↵
    Als H, Duffy FH, McAnulty GB, et al. Early experience alters brain function and structure. Pediatrics 2004;113:846–857

    Abstract/FREE Full Text
26. ↵
    Tooley JR, Eagle RC, Satas S, Thoresen M. Significant head cooling can be achieved while maintaining normothermia in the newborn piglet. Arch Dis Child Fetal Neonatal Ed 2005;90:F262–F266

    Abstract/FREE Full Text
27. ↵
    Strunk T, Hartel C, Schultz C. Does erythropoietin protect the preterm brain? Arch Dis Child Fetal Neonatal Ed 2004;89:F364–F366

    Abstract/FREE Full Text
28. ↵
    Follett PL, Deng W, Dai W, et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 2004;24:4412–4420

    Abstract/FREE Full Text
29. ↵
    Gressens P, Besse L, Robberecht P, et al. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives. J Pharmacol Exp Ther 1999;288:1207–1213

    Abstract/FREE Full Text